We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

NeoCart Phase 2 Clinical Trial

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: October 23, 2007
Last Update Posted: April 21, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Histogenics Corporation
The objective of this study is to gather additional information regarding the performance of NeoCart to fill articular cartilage defects in the knee.

Condition Intervention Phase
Articular Cartilage Damage Biological: NeoCart Procedure: microfracture Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee

Further study details as provided by Histogenics Corporation:

Primary Outcome Measures:
  • The safety and preliminary efficacy of NeoCart will be compared to conventional microfracture therapy. [ Time Frame: One year ]

Secondary Outcome Measures:
  • This study will extend the experience derived from our Phase 1 study. [ Time Frame: One year ]

Enrollment: 30
Study Start Date: December 2006
Study Completion Date: March 2014
Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: NeoCart Biological: NeoCart
autologous tissue implant
Active Comparator: microfracture Procedure: microfracture


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients presenting with symptomatic knee pain indicative of an articular cartilage injury and able and willing to give informed consent.

Exclusion Criteria:

  • Patients with any previous surgical treatment other than debridement or microfracture of the study cartilage defect.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00548119

United States, California
San Francisco, California, United States, 94143
United States, Minnesota
TRIA Orthopedic Center
Bloomington, Minnesota, United States
United States, New York
Hospital for Special Surgery
New York, New York, United States, 10021
Keller Army Community Hospital
West Point, New York, United States
United States, North Carolina
Duke Sports Medicine Center
Durham, North Carolina, United States, 27710
United States, Oregon
Portland, Oregon, United States
Sponsors and Collaborators
Histogenics Corporation
  More Information

Responsible Party: Histogenics Corporation
ClinicalTrials.gov Identifier: NCT00548119     History of Changes
Other Study ID Numbers: 6-01
First Submitted: October 19, 2007
First Posted: October 23, 2007
Last Update Posted: April 21, 2014
Last Verified: March 2014